外周血淋巴细胞亚群与乳腺癌的关系

Relationship between Peripheral Blood Lymphocyte Subsets and Breast Cancer

乳腺癌发病率于2020年超越肺癌,位居全球癌症发病率首位。目前乳腺癌的诊断以空芯针穿刺活组织病理检查作为权威标准,但是需要实体瘤有一定的体积,如若在肿瘤发生的早期,穿刺活检注定无法实现。根据现有的研究来看,癌症的发生可能与人体内的炎症系统和免疫系统的改变有关。在癌症发生时,外周血淋巴细胞会有什么具体的改变值得我们进一步去探寻。本文将探讨外周血淋巴细胞与乳腺癌的关系,为乳腺癌的提前诊疗提供一种新的方法,这一研究无疑将为乳腺癌的诊断带来新的突破。

The incidence of breast cancer surpassed lung cancer in 2020 and became the first cancer incidence in the world. Core needle biopsy is the authoritative standard for the diagnosis of breast cancer at present, but it requires a certain volume of solid tumor. If the tumor is in the early stage, needle biopsy is destined to be impossible. According to the existing research, the occurrence of cancer may be related to the changes of the inflammatory system and immune system in the human body. The specific changes in peripheral blood lymphocytes during the occurrence of cancer are worth further exploration. This article will explore the relationship between peripheral blood lympho-cytes and breast cancer, and provide a new method for the early diagnosis and treatment of breast cancer, which will undoubtedly bring new breakthroughs in the diagnosis of breast cancer.